NORTHAMPTON, MA / ACCESSWIRE / December 7, 2022 / The Parker Family Health Center, which provides free medical care for Monmouth County, New Jersey residents ages 3 and up who are uninsured, has joined forces with Quest for Health Equity (Q4HE) to provide comprehensive, no-cost laboratory testing. The no-cost testing applies at the time of the patient's medical visit and as a scheduled service at the health center.
"This access to laboratory testing enhances our ability to provide timely and relevant medical care to our patients," said Suzy Dyer, Executive Director of Parker Family Health Center. "Our patients come from diverse cultural backgrounds, many with significant socioeconomic barriers limiting their access to healthcare, especially diagnostic and laboratory testing."
Parker Family Health Center, based in Red Bank, New Jersey, received donated lab testing from Quest Diagnostics as part of the Q4HE initiative to support the center's mission.
"We are proud to support this important program that gives access to lab testing that will help provide accurate and critical care to these patients," said Michael Floyd, Senior Director, Q4HE. "We believe that good health should be in reach for everyone and by working with Parker Family Health Center, we are one step closer for these patients."
"Our patients, staff and medical professionals are delighted to have Quest for Health Equity partnering with us to ensure increased access to healthcare for all our patients," said Suzy. "One of our patients recently shared with the phlebotomist that she is so happy that the bloodwork is now being done on-site."
Click here to learn more about the comprehensive services Parker Family Health Center offers in Monmouth County.
View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.
Contact Info:
Spokesperson: Quest Diagnostics
Website: http://www.questdiagnostics.com
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$163.59 |
Daily Change: | -0.30 -0.18 |
Daily Volume: | 565,007 |
Market Cap: | US$18.260B |
October 23, 2024 October 22, 2024 October 15, 2024 September 18, 2024 August 26, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB